Tenax Therapeutics, Inc.
TENX
$14.61
$0.775.53%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 97.57M | 99.37M | 105.46M | 111.45M | 94.85M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 5.64M | 3.44M | 395.00K | 524.00K | 1.77M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.02M | -- | -- | 88.00K | 64.00K |
| Total Current Assets | 104.23M | 102.81M | 105.86M | 112.06M | 96.69M |
|
|
|||||
| Total Current Assets | 104.23M | 102.81M | 105.86M | 112.06M | 96.69M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 104.23M | 102.81M | 105.86M | 112.06M | 96.69M |
|
|
|||||
| Total Accounts Payable | 6.04M | 5.61M | 562.00K | 1.84M | 3.16M |
| Total Accrued Expenses | 1.12M | 991.00K | 1.97M | 929.00K | 1.54M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 7.16M | 6.60M | 2.53M | 2.77M | 4.69M |
|
|
|||||
| Total Current Liabilities | 7.16M | 6.60M | 2.53M | 2.77M | 4.69M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 7.16M | 6.60M | 2.53M | 2.77M | 4.69M |
|
|
|||||
| Common Stock & APIC | 464.53M | 448.13M | 439.44M | 434.55M | 406.85M |
| Retained Earnings | -367.45M | -351.91M | -336.11M | -325.26M | -314.86M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 97.07M | 96.21M | 103.33M | 109.29M | 91.99M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 97.07M | 96.21M | 103.33M | 109.29M | 91.99M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 97.07M | 96.21M | 103.33M | 109.29M | 91.99M |
|
|
|||||